Group Leader
at Children's Cancer Institute
Professor Murray Norris PhD co-leads the Experimental Therapeutics and Molecular Oncology group in the Children’s Cancer Institute. Formerly deputy director (2000 – 2023), he was also the inaugural director (2015-2024) of the University of New South Wales Centre for Childhood Cancer Research.
Murray’s research has focused on utilizing new molecular technologies to improve the diagnosis, risk classification and treatment of childhood cancer. He has been responsible for developing and implementing unique technology enabling the molecular detection of minimal residual disease for the early prediction of relapse in children with acute lymphoblastic leukemia.
Murray has published more than 200 peer-reviewed papers, and his research has been recognized by several awards, including the inaugural Sally Crossing AM Award for an Outstanding Outcome in Cancer Research in 2019. He was appointed a Member of the Order of Australia in 2015 for significant service to medical research as a molecular biologist and through pioneering development of treatments for cancer in children.
Education
University of New South Wales, Australia
Awards & Certifications
Sally Crossing AM Award for an Outstanding Outcome in Cancer Research in 2019
Accreditations
Member recognised by Order of Australia
Member recognised by American Association for Cancer Research
Member recognised by Advances in Neuroblastoma Research Association
Member recognised by Australian Society for Medical Research
Member recognised by Australian Society for Biochemistry and Molecular Biology
Areas of Expertise
Got a Question for Professor Murray Norris AM PhD?
Get in touch using the contact form linked here and we’ll get back to you shortly
